THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS

Ivan Stockley,

doi:10.1515/DMDI.1980.3.1-2.1

Home THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS

Article

Licensed

Unlicensed Requires Authentication

THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS

Ivan Stockley,

Published/Copyright: December 1, 1980

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

From the journal Drug Metabolism and Drug Interactions Volume 3 Issue 1-2

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Stockley,, Ivan. "THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS" Drug Metabolism and Drug Interactions, vol. 3, no. 1-2, 1980, pp. 1-30. https://doi.org/10.1515/DMDI.1980.3.1-2.1

Stockley,, I. (1980). THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS. Drug Metabolism and Drug Interactions, 3(1-2), 1-30. https://doi.org/10.1515/DMDI.1980.3.1-2.1

Stockley,, I. (1980) THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS. Drug Metabolism and Drug Interactions, Vol. 3 (Issue 1-2), pp. 1-30. https://doi.org/10.1515/DMDI.1980.3.1-2.1

Stockley,, Ivan. "THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS" Drug Metabolism and Drug Interactions 3, no. 1-2 (1980): 1-30. https://doi.org/10.1515/DMDI.1980.3.1-2.1

Stockley, I. THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS. Drug Metabolism and Drug Interactions. 1980;3(1-2): 1-30. https://doi.org/10.1515/DMDI.1980.3.1-2.1

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 1980-12

You are currently not able to access this content.

Articles in the same Issue

CONTENTS
THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS
DRUG INTERACTION INVOLVING ORAL CONTRACEPTIVES
PHARMACOTOXICOLOGIC INTERACTIONS BETWEEN DRUGS AND ANTIBIOTICS †
METABOLIC DISPOSITION OF CLOFIBRATE
2'-DEOXYCOFORMYCIN AND OTHER ADENOSINE DEAMINASE INHIBITORS
THE MECHANISMS OF THE MUSCLE PARALYSING ACTIONS OF ANTIBIOTICS, AND THEIR INTERACTION WITH NEUROMUSCULAR BLOCKING AGENTS

Search journal Search the content of this journal

https://doi.org/10.1515/DMDI.1980.3.1-2.1

Articles in the same Issue

CONTENTS
THE ROLE OF DRUG METABOLISM IN THE DEVELOPMENT OF CLINICALLY SIGNIFICANT ADVERSE DRUG INTERACTIONS
DRUG INTERACTION INVOLVING ORAL CONTRACEPTIVES
PHARMACOTOXICOLOGIC INTERACTIONS BETWEEN DRUGS AND ANTIBIOTICS †
METABOLIC DISPOSITION OF CLOFIBRATE
2'-DEOXYCOFORMYCIN AND OTHER ADENOSINE DEAMINASE INHIBITORS
THE MECHANISMS OF THE MUSCLE PARALYSING ACTIONS OF ANTIBIOTICS, AND THEIR INTERACTION WITH NEUROMUSCULAR BLOCKING AGENTS